sertraline has been researched along with Dysthymic Disorder in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (37.14) | 18.2507 |
2000's | 20 (57.14) | 29.6817 |
2010's | 2 (5.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, S; Comstock, B; Cukor, D; Daniel, DM; Dember, LM; Diaz-Linhart, Y; Dubovsky, A; Greene, T; Grote, N; Heagerty, P; Hedayati, SS; Katon, W; Kimmel, PL; Kutner, N; Linke, L; Mehrotra, R; Quinn, D; Rue, T; Trivedi, MH; Unruh, M; Weisbord, S; Young, BA | 1 |
Barbour, K; Burg, M; Jaffe, A; Taylor, CB; Trockel, M | 1 |
Geerts, E; Gerlsma, C; van Os, T | 1 |
Dadić-Hero, E; Grahovac, T; Graovac, M; Palijan, TZ; Ružić, K; Sepić-Grahovac, D | 1 |
Baca, E; García-Toro, M; González de Chávez, M; Pérez-Arnau, F; Porras-Chavarino, A | 1 |
Anton, RF; Durazo-Arvizu, R; Latham, PK; Moak, DH; Voronin, KE; Waid, RL | 1 |
Ros, LT | 1 |
Bastiaens, L | 1 |
Bleiberg, KL; Christos, PJ; Kocsis, JH; Markowitz, JC; Sacks, M | 1 |
Anisman, H; Kelly, O; Matheson, K; Merali, Z; Ravindran, A | 1 |
Clary, CM; Harvey, AT; Kornstein, SG; Silkey, BS | 1 |
Davidson, J; Halbreich, U; Hellerstein, DJ; Kocsis, JH; Rosenbaum, J; Shelton, R; Yonkers, K; Zisook, S | 1 |
Davidson, J; Halbreich, U; Koran, L; Pearlstein, T; Shelton, RC; Thase, ME; Yonkers, KA | 1 |
Fava, M; Nierenberg, AA; Pearlstein, T; Quitkin, FM; Rosenbaum, JF; Stone, A; Zisook, S | 1 |
Baldessarini, RJ; Bodkin, JA; Gardner, DM; Lasser, RA; Wines, JD | 1 |
Buni, TM | 1 |
de Jonghe, F | 1 |
Keck, PE; McElroy, SL; Soutullo, CA | 1 |
Fawcett, JA; Gelenberg, AJ; Harrison, WM; Hirschfeld, RM; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Markowitz, JC; McCullough, JP; Miceli, RJ; Rush, AJ; Schatzberg, AF; Thase, ME | 1 |
Davis, SM; Fawcett, JA; Gelenberg, AJ; Harrison, WM; Hirschfeld, RM; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Kornstein, SG; Markowitz, JC; McCullough, JP; Rush, AJ; Russell, JM; Thase, ME | 1 |
Davis, SM; Harrison, WM; Keitner, GI; Keller, MB; Klein, DN; Kornstein, SG; Markowitz, JC; Miller, IW; Rush, AJ; Schatzberg, AF; Schlager, DS; Thase, ME | 1 |
Gaynes, BN; Golden, RN; McLeod, MN | 1 |
Anisman, H; Bialik, RJ; Charbonneau, Y; Ellis, J; Griffiths, J; Merali, Z; Ravindran, AV; Telner, J; Wiens, A | 1 |
Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV | 1 |
Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV; Zaharia, MD | 1 |
Chapman, D; Harrison, W; Hellerstein, DJ; Kocsis, JH; Stewart, JW | 1 |
Davis, SM; Gelenberg, AJ; Harrison, WM; Keitner, GI; Keller, MB; Kornstein, SG; McCullough, JP; Schatzberg, AF; Thase, ME; Yonkers, KA | 1 |
Cassano, GB; Guelfi, JD; Lane, RM; Ravindran, AV | 1 |
Marsland, TW; Newton, W | 1 |
DeBattista, C; Friedman, RA; Gelenberg, AJ; Hirschfeld, RM; Howland, RH; Keller, MB; Klein, D; Kocsis, JH; Koran, LM; Kornstein, SG; LaVange, LM; Rush, AJ; Schatzberg, AF; Thase, ME | 1 |
Cloutier, P; Milin, R; Nixon, MK; Simeon, JG; Spenst, W | 1 |
Amore, M; Jori, MC | 1 |
Reich, J | 1 |
Fawcett, J; Gelenberg, AJ; Harrison, W; Hirschfeld, RM; Howland, RH; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Kornstein, SG; LaVange, LM; Rush, AJ; Russell, JM; Schatzberg, AF; Thase, ME | 1 |
Bell, B; Browne, G; Byrne, C; Chalklin, L; Dunn, E; Gafni, A; Kraemer, J; Mills, M; Roberts, J; Steiner, M; Wallik, D | 1 |
26 trial(s) available for sertraline and Dysthymic Disorder
Article | Year |
---|---|
Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND).
Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Comorbidity; Depression; Depressive Disorder, Major; Dysthymic Disorder; Humans; Kidney Failure, Chronic; Renal Dialysis; Sertraline; Treatment Outcome | 2016 |
Smoking behavior postmyocardial infarction among ENRICHD trial participants: cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual.
Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Personality Inventory; Sertraline; Sick Role; Smoking; Smoking Cessation; Social Support | 2008 |
Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicentre, randomized study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Sertraline | 2003 |
Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.
Topics: Adult; Alcoholics Anonymous; Alcoholism; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients.
Topics: Adolescent; Adult; Antidepressive Agents; Combined Modality Therapy; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Psychotherapy; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status.
Topics: Adult; Cross-Over Studies; Depressive Disorder, Major; Disease Progression; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Menopause; Middle Aged; Patient Dropouts; Sertraline; Sex Factors; Treatment Outcome | 2007 |
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
Topics: 1-Naphthylamine; Adult; Age of Onset; Aged; Antidepressive Agents; Double-Blind Method; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Placebos; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Social Adjustment; Treatment Outcome | 1997 |
The undertreatment of dysthymia.
Topics: 1-Naphthylamine; Adult; Age of Onset; Aged; Ambulatory Care; Antidepressive Agents; Comorbidity; Dysthymic Disorder; Family; Female; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Personality Disorders; Placebos; Prevalence; Psychiatric Status Rating Scales; Psychotherapy; Sertraline; Single-Blind Method; Treatment Outcome | 1997 |
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
Topics: 1-Naphthylamine; Adult; Aged; Anger; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline | 1997 |
Treatment of dysthymia.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
Topics: Antidepressive Agents, Tricyclic; Chronic Disease; Clinical Protocols; Comorbidity; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Dysthymic Disorder; Follow-Up Studies; Humans; Imipramine; Patient Dropouts; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Patient Selection; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Follow-Up Studies; Health Status; Humans; Imipramine; Male; Middle Aged; Personal Satisfaction; Personality Inventory; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Adjustment; Surveys and Questionnaires; Treatment Outcome | 1998 |
Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients.
Topics: Adult; Antidepressive Agents; Ascorbic Acid; Chromium; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Picolinic Acids; Sertraline; Single-Blind Method; Treatment Outcome | 1999 |
Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments.
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Placebos; Psychotherapy, Group; Sertraline; Treatment Outcome | 1999 |
Interleukin-1 beta production in dysthymia before and after pharmacotherapy.
Topics: Adult; Age of Onset; Analysis of Variance; Antidepressive Agents; Biomarkers; Double-Blind Method; Dysthymic Disorder; Female; Humans; Hydrocortisone; Interleukin-1; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 1999 |
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Fluoxetine; Humans; Immune Tolerance; Lymphocyte Activation; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Venlafaxine Hydrochloride | 2000 |
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality.
Topics: Adult; Age of Onset; Antidepressive Agents, Tricyclic; Double-Blind Method; Dysthymic Disorder; Factor Analysis, Statistical; Female; Humans; Imipramine; Male; Personality; Personality Inventory; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Adjustment; Temperament; Treatment Outcome | 2000 |
Gender differences in treatment response to sertraline versus imipramine in chronic depression.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Estrogens; Female; Humans; Imipramine; Male; Middle Aged; Patient Dropouts; Placebos; Premenopause; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sex Factors; Treatment Outcome | 2000 |
Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Topics: Adolescent; Adult; Aged; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Are there differences by gender in response to pharmacotherapy for depression?
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Confounding Factors, Epidemiologic; Depressive Disorder; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome | 2000 |
Sertraline versus imipramine to prevent relapse in chronic depression.
Topics: Adult; Aged; Chronic Disease; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Sertraline | 2001 |
Sertraline effects in adolescent major depression and dysthymia: a six-month open trial.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Depressive Disorder; Dysthymic Disorder; Female; Humans; Male; Psychiatric Status Rating Scales; Sertraline | 2001 |
Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Sulpiride | 2001 |
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
Topics: Adult; Cross-Over Studies; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Prospective Studies; Sertraline; Treatment Outcome | 2002 |
Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.
Topics: Adolescent; Adult; Aged; Canada; Combined Modality Therapy; Cost-Benefit Analysis; Depressive Disorder, Major; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Care Team; Primary Health Care; Psychotherapy; Sertraline; Single-Blind Method; Treatment Outcome | 2002 |
9 other study(ies) available for sertraline and Dysthymic Disorder
Article | Year |
---|---|
Nonverbal communication sets the conditions for the relationship between parental bonding and the short-term treatment response in depression.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Interview, Psychological; Male; Middle Aged; Nonverbal Communication; Object Attachment; Parent-Child Relations; Parenting; Personality Inventory; Prognosis; Recurrence; Sertraline; Treatment Outcome; Young Adult | 2009 |
Allergic reactions--outcome of sertraline and escitalopram treatments.
Topics: Adult; Angioedema; Antidepressive Agents; Citalopram; Combined Modality Therapy; Drug Eruptions; Drug Hypersensitivity; Dysthymic Disorder; Female; Humans; Psychotherapy; Psychotherapy, Group; Sertraline | 2011 |
A case of "double" depression under outpatient treatment conditions.
Topics: Adult; Ambulatory Care; Anticonvulsants; Carbamazepine; Clonazepam; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Dysthymic Disorder; Electroencephalography; Epilepsy, Temporal Lobe; Female; Humans; International Classification of Diseases; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2004 |
Adolescents' response to antidepressant treatment in a community mental health center.
Topics: Adolescent; Adolescent Psychiatry; Algorithms; Antidepressive Agents; Child; Child Psychiatry; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Ruminative coping among patients with dysthymia before and after pharmacotherapy.
Topics: Adaptation, Psychological; Adult; Cognition; Dysthymic Disorder; Female; Humans; Individuality; Male; Problem Solving; Recurrence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2007 |
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Anxiety Disorders; Bupropion; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Epilepsy; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Sertraline and imipramine for the treatment of dysthymia.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Dysthymic Disorder; Humans; Imipramine; Placebos; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Hypomania associated with mirtazapine augmentation of sertraline.
Topics: 1-Naphthylamine; Ambulatory Care; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Personality change after treatment.
Topics: Double-Blind Method; Dysthymic Disorder; Humans; Imipramine; Personality Assessment; Personality Disorders; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2002 |